AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates
May 08, 2018 20:15 pm UTC| Business
Positive Phase 2a Proof-of-Concept Data Reported from ANB020 Trials in Atopic Dermatitisand Peanut Allergy Top-Line Phase 2a Data from ANB020 in Eosinophilic Asthma Expected in the Third Quarter of 2018 SAN DIEGO, May ...
CloudGenix Announces SD-WAN Investment to Drive Software-based Transformation of Networks
May 08, 2018 20:15 pm UTC| Business
SAN JOSE, Calif., May 08, 2018 -- CloudGenix, a leader in Software-Defined Wide Area Networking (SD-WAN) today announced an investment from Intel Capital to drive the software-based transformation of networks....
KAR Auction Services, Inc. Reports First Quarter 2018 Financial Results
May 08, 2018 20:15 pm UTC| Business
First quarter 2018 revenue increased 10% to $950.5 million.Net Income Per Share increased 32%, Operating Adjusted Net Income Per Share increased 32% and Adjusted EBITDA increased 9% over the three months ended March 31,...
Versartis Reports First Quarter 2018 Financial Results
May 08, 2018 20:15 pm UTC| Business
MENLO PARK, Calif., May 08, 2018 -- Versartis, Inc. (Nasdaq:VSAR), an endocrine-focused biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2018. “We have undertaken...
May 08, 2018 20:15 pm UTC| Business
NEW YORK, May 08, 2018 -- I-AM Capital Acquisition Company (NASDAQ:IAM) (“I-AM Capital”), announced that it has entered into a Definitive Agreement with SMAAASH Entertainment Private Limited (“SMAAASH”), a global...
May 08, 2018 20:15 pm UTC| Business
ANDOVER, Mass., May 08, 2018 -- Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com) announced it received a $3.8 million order from a leading electronics manufacturing services provider for millimeter wave transceiver...
ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update
May 08, 2018 20:15 pm UTC| Business
WESTMINSTER, Colo., May 08, 2018 -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today...